Author

Kaori Okada

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Akane YamamichiiD· 2 shared Atsuro SaijoiD· 2 shared Hideho OkadaiD· 2 shared Marco GallusiD· 2 shared Senthilnath LakshmanachettyiD· 2 shared Takahide NejoiD· 2 shared Aaron DiaziD· 1 shared Abhilash BarpandaiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Akane YamamichiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 19, 2026

Ultrasound-mediated blood-brain barrier modulation enhances T-cell access but requires immune activation for effective CNS immunity

Marco Gallus, Akane Yamamichi, Victor Andrés Arrieta…·Hideho Okada

This study shows that ultrasound-mediated BBB modulation alone does not generate effective CNS immunity, but combining it with systemic immune activation enhances T-cell responses and improves immunotherapy efficacy.

DOI 10.64898/2026.08.14.744698

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 19, 2023

Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens

Darwin W. Kwok, Nicholas O. Stevers, Takahide Nejo…·Hideho Okada

The paper identifies tumor-wide splicing aberrations that generate public neoantigens, enabling T-cell-based immunotherapies targeting intratumoral heterogeneity.

DOI 10.1101/2023.10.19.563178

humanbulk RNA-seq

𝕏 PostBluesky